Two recent observations linking these phenobarbital-induced changes in the liver with modifications of bilirubin metabolism have caught the fancy of hepatologists. As discussed by Robinson et al.
UCB, a global biopharmaceutical company, announced today that a single-injection 2 mL prefilled syringe and autoinjector, each containing 320 mg of ...